{
  "id": "5160b634b9370bea",
  "title": "IGC Pharma Secures North American Composition Protection for IGC - AD1 as Phase 2 CALMA Enrollment Advances",
  "description": "20260217T161500Z",
  "content": "",
  "source": "tennesseedaily.com",
  "source_url": "http://www.tennesseedaily.com/news/278873270/igc-pharma-secures-north-american-composition-protection-for-igc-ad1-as-phase-2-calma-enrollment-advances",
  "published_at": "20260217T161500Z",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "llm"
  ],
  "location": "United States",
  "raw_data": {
    "url": "http://www.tennesseedaily.com/news/278873270/igc-pharma-secures-north-american-composition-protection-for-igc-ad1-as-phase-2-calma-enrollment-advances",
    "url_mobile": "",
    "title": "IGC Pharma Secures North American Composition Protection for IGC - AD1 as Phase 2 CALMA Enrollment Advances",
    "seendate": "20260217T161500Z",
    "socialimage": "",
    "domain": "tennesseedaily.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}